Liqun Gu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Cardiac Resynchronization Therapy

Locally Advanced

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yves Boucher, Jessica M Posada, Sonu Subudhi, Ashwin Srinivasan Kumar, Spencer R Rosario, Liqun Gu, Heena Kumra, Mari A Mino-Kenudson, Nilesh P Talele, Dan G Duda, Dai Fukumura, Jennifer Y Wo, Jeffrey W Clark, David P Ryan, Carlos F Fernandez-Del Castillo, Theodore S Hong, Mikaël J Pittet, Rakesh K Jain
Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs and FOXP3+ cancer cells in locally advanced pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yves Boucher, Jessica M Posada, Sonu Subudhi, Ashwin Srinivasan Kumar, Spencer R Rosario, Liqun Gu, Heena Kumra, Mari A Mino-Kenudson, Nilesh P Talele, Dan G Duda, Dai Fukumura, Jennifer Y Wo, Jeffrey W Clark, David P Ryan, Carlos F Fernandez-Del Castillo, Theodore S Hong, Mikaël J Pittet, Rakesh K Jain
Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs and FOXP3+ cancer cells in locally advanced pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yves Boucher, Jessica M Posada, Sonu Subudhi, Ashwin Srinivasan Kumar, Spencer R Rosario, Liqun Gu, Heena Kumra, Mari A Mino-Kenudson, Nilesh P Talele, Dan G Duda, Dai Fukumura, Jennifer Y Wo, Jeffrey W Clark, David P Ryan, Carlos F Fernandez-Del Castillo, Theodore S Hong, Mikaël J Pittet, Rakesh K Jain
Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs and FOXP3+ cancer cells in locally advanced pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)